Dr. Gill named University of Southern California chair of urology

Article

Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1.

Inderbir S. Gill, MD, has been appointed chair of the University of Southern California, Los Angeles Catherine and Joseph Aresty Department of Urology, effective Feb. 1. He will also be the director of the newly created USC Institute of Urology and will serve as associate dean for clinical innovation at USC’s Keck School of Medicine.

Dr. Gill comes to USC from Cleveland Clinic, where he was chairman of the department of urology. He also served as director of the Center of Laparoscopic and Robotic Surgery and professor of surgery at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve University.

Dr. Gill has identified several goals at USC, including creating a world-renowned USC Institute of Urology with regional satellites; providing an entire range of sub-specialization; strengthening USC urology’s basic, translational, and outcomes research programs with focus on inter-disciplinary collaboration; growing USC urology’s residency training program; and creating new teaching programs and targeted symposia to position USC as a leading educational resource in the field of urology.

In other recent personnel changes:

The University of Michigan, Ann Arbor, has appointed Kenneth J. Pienta, MD, as associate dean for clinical and translational research at the U-M Medical School and director of the Michigan Institute of Clinical and Health Research. Dr. Pienta is a professor of internal medicine and urology; director of the urologic oncology program, U-M Comprehensive Cancer Center; and director of the Experimental Therapeutics for the Michigan Center for Translational Pathology.

R. Dale McClure, MD, has been named president of the American Society for Reproductive Medicine. Dr. McClure serves as director of male infertility and of the microsurgical unit at the Virginia Mason Clinic in Seattle. “As only the third urologist to serve as president of the ASRM, I look forward to promoting our role as the leading experts in all areas of reproduction and sexuality,” he said.

Karen Lencoski, JD, MBA, has been appointed as the new AUA government relations and advocacy manager. Lencoski, a health policy attorney, brings more than 10 years of government relations experience to the position, including serving as a director with the Society of General Internal Medicine and with scientific and commercial relations at Sanofi Aventis Pharmaceuticals. Lencoski’s primary responsibilities will include promoting AUA’s federal legislative agenda on Capitol Hill and keeping AUA members informed of important legislative updates.

Related Videos
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
Related Content
© 2024 MJH Life Sciences

All rights reserved.